1. Home
  2. BCPC vs INDV Comparison

BCPC vs INDV Comparison

Compare BCPC & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Balchem Corporation

BCPC

Balchem Corporation

HOLD

Current Price

$160.13

Market Cap

5.6B

Sector

Industrials

ML Signal

HOLD

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$37.81

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCPC
INDV
Founded
1967
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
4.7B
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
BCPC
INDV
Price
$160.13
$37.81
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$176.00
N/A
AVG Volume (30 Days)
163.3K
2.0M
Earning Date
04-30-2026
06-08-2026
Dividend Yield
0.55%
N/A
EPS Growth
20.87
8100.00
EPS
1.25
0.69
Revenue
$799,023,000.00
$1,239,000,000.00
Revenue This Year
$8.47
N/A
Revenue Next Year
$4.89
N/A
P/E Ratio
$128.96
$54.70
Revenue Growth
13.56
4.29
52 Week Low
$139.17
$11.08
52 Week High
$183.90
$41.00

Technical Indicators

Market Signals
Indicator
BCPC
INDV
Relative Strength Index (RSI) 40.23 58.90
Support Level $159.00 $29.71
Resistance Level $165.24 $37.83
Average True Range (ATR) 3.58 1.36
MACD -0.10 -0.32
Stochastic Oscillator 47.00 37.98

Price Performance

Historical Comparison
BCPC
INDV

About BCPC Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: